Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation

Clinical and Experimental Immunology

Volumn 155, Issue 3, 2009, Pages 496-503

  Wang, Z ^a   Shi, B Y ^a   Qian, Y Y ^a   Cai, M ^a   Wang, Q ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Basiliximab; CD4+CD25+FoxP3+ T reg cells; IL 2; IL 2R; Kidney transplantation

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ALPHA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; TRANSCRIPTION FACTOR FOXP3;

ADULT; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE REDUCTION; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BIOLOGICAL MARKERS; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 59249104295     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03847.x     Document Type: Article

References (30)

1. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory t cell populations by foreign antigen. Nat Immunol 2005 6 : 1219 27.
2. + cells in renal allografts during acute rejection. Am J Transplant 2007 7 : 914 22.
3. bright+ Regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant 2006 6 : 2955 64.
4. + regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection. Transplantation 2006 82 : 1202 9.
5. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2R beta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002 17 : 167 78.
6. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993 75 : 253 61.
7. Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC. Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation 2004 7 : 166 76.
8. Bingyi S, Yeyong Q, Ming C, Chunbai M, Wenqiang Z. Randomised trial of Simulect versus placebo for control of acute rejection in renal allograft recipients. Transplant Proc 2003 35 : 192 4.
9. Bingyi S, Ming C, Yeyong Q, Chunbai M, Wenqiang Z. The effect of anti-CD25 monoclonal antibody (Simulect) to the lymphocytes in the peripheral blood of the recipients of kidney transplantation. Transplant Proc 2003 35 : 243 5.
10. Game DS, Hernandez-Fuentes MP, Lechler RI. Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro. Am J Transplant 2005 5 : 454 64.
11. high regulatory T cells in kidney transplantation. Transpl Immunol 2008 19 : 69 73.
12. high regulatory cells in human peripheral blood. J Immunol 2001 167 : 1245 53.
13. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 61.
14. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, Bonnefoy-Berard N. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 1998 91 : 2360 8.
15. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004 22 : 531 62.
16. + memory T cells by opposing cytokines. Science 2000 288 : 675 8.
17. Nakamura Y, Russell SM, Mess SA et al. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature 1994 369 : 330 3.
18. van de Linde P, Tysma OM, Medema JP et al. Mechanisms of antibody immunotherapy on clonal islet reactive T cells. Hum Immunol 2006 67 : 264 73.
19. +CD25+ T regulatory cells. J Immunol 2006 176 : 3301 5.
20. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005 6 : 1142 51.
21. - naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003 198 : 1875 86.
22. Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 2006 311 : 1924 7.
23. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005 22 : 329 41.
24. Gavin MA, Rasmussen JP, Fontenot JD et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007 445 : 771 5.
25. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007 8 : 277 84.
26. Wu Y, Borde M, Heissmeyer V et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006 126 : 375 87.
27. Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007 446 : 685 9.
28. + subset of human CD4+CD25+ regulatory T cells. Blood 2006 107 : 1018 23.
29. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001 167 : 1945 53.
30. +CD25+ regulatory T-cell pool is present in renal transplant recipients. Am J Transplant 2007 7 : 249 55.